Bibliography
- JACKSON JR, PATRICK DR, DAR MM, HUANG PS: Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat. Rev. Cancer (2007) 7(2):107-117.
- SARLI V, GIANNIS A: Inhibitors of mitotic kinesins: next-generation antimitotics. Chem. Med. Chem. (2006) 1(3):293-298.
- JIANG C, YOU Q, LI Z, GUO Q: Kinesin spindle protein inhibitors as anticancer agents. Expert Opin. Ther. Patents (2006) 16(11):1517-1532.
- COLEMAN PJ, FRALEY ME: Inhibitors of the mitotic kinesin spindle protein. Expert Opin. Ther. Patents (2004) 14(12):1659-1667.
- LIU F, YOU QD, CHEN YD: Pharmacophore identification of KSP inhibitors. Bioorg. Med. Chem. Lett. (2007) 17(3):722-726.
- DUHL DM, RENHOWE PA: Inhibitors of kinesin motor proteins – research and clinical progress. Curr. Opin. Drug Discov. Dev. (2005) 8(4):431-436.
- BERGNES G, QIAN X, WOLFF AA: Progress on mitotic kinesin inhibitors as anti-cancer therapeutics. Ann. Rep. Med. Chem. (2006) 41:263-274.
- BERGNES G, BREJC K, BELMONT L: Mitotic kinesins: prospects for antimitotic drug discovery. Curr. Topics Med. Chem. (2005) 5(2):127-145.
Patents
- MERCK & CO., INC.: WO2005102996 (2005).
- ARRAY BIOPHARMA, INC.: WO2006044825 (2006).
- CHIRON CORPORATION: WO2004111058 (2004).
- CHIRON CORPORATION: WO2004113335 (2004).
- CHIRON CORPORATION: WO2005051922 (2005).
- CHIRON CORPORATION: US20050228002 (2005).
- CHIRON CORPORATION: US20050261337 (2005).
- CHIRON CORPORATION: WO2006002236 (2006).
- CHIRON CORPORATION: WO2006049835 (2006).
Websites
- http://www.cytokinetics.com/cyto/pr_1179477640 Cytokinetics press release on presentation of clinical trial data for ispinesib and SB743921, May 2007.
- http://clinicaltrials.gov/ct/show/NCT00104364;jsessionid=27011BC97F8B027ACCC130D5F6A1BC4E?order=3 NIH clinical trials website listing active trial for MK0731, May 2007.
- http://phx.corporate-ir.net/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=995153 Array Biopharma press release on ARRY520, May 2007.